Mixed Endothelin Receptor Antagonism With Tezosentan Improves Intestinal Microcirculation in Endotoxemic Shock

Journal of Surgical Research

Volumn 149, Issue 1, 2008, Pages 138-147

  Andersson, Andreas ^a   Fenhammar, Johan ^a   Frithiof, Robert ^b   Weitzberg, Eddie ^b   Sollevi, Alf ^a   Hjelmqvist, Hans ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

endothelin; endotoxin; gut; laser Doppler; microcirculation; sepsis; shock; tezosentan

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN RECEPTOR; ENDOTOXIN; HEMOGLOBIN; TEZOSENTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBON DIOXIDE TENSION; COLON MUCOSA; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFECT; ENDOTOXEMIA; FEMALE; HEART INDEX; HEART RATE; HEMODYNAMICS; HEMOGLOBIN DETERMINATION; ILEUM MUCOSA; INTESTINE BLOOD FLOW; LASER DOPPLER FLOWMETRY; LIVER BLOOD FLOW; MEAN ARTERIAL PRESSURE; MICROCIRCULATION; NONHUMAN; PH; PORTAL VEIN BLOOD FLOW; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION PRESSURE; SPLANCHNIC BLOOD FLOW; SWINE;

ANIMALS; FEMALE; INTESTINAL DISEASES; INTESTINES; LASER-DOPPLER FLOWMETRY; MICROCIRCULATION; PYRIDINES; RECEPTORS, ENDOTHELIN; SHOCK, SEPTIC; SPLANCHNIC CIRCULATION; SWINE; TETRAZOLES; VASCULAR DISEASES; VASODILATOR AGENTS;

EID: 48949098245     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2007.12.751     Document Type: Article

References (48)

1. Annane D., Bellissant E., and Cavaillon J.M. Septic shock. Lancet 365 (2005) 63
2. Rivers E., Nguyen B., Havstad S., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345 (2001) 1368
3. Ince C. The microcirculation is the motor of sepsis. Crit Care 9 (2005) S13
4. Sakr Y., Dubois M.J., De Backer D., et al. Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med 32 (2004) 1825
5. Buwalda M., and Ince C. Opening the microcirculation: Can vasodilators be useful in sepsis?. Intensive Care Med 28 (2002) 1208
6. Hiltebrand L.B., Krejci V., Banic A., et al. Dynamic study of the distribution of microcirculatory blood flow in multiple splanchnic organs in septic shock. Crit Care Med 28 (2000) 3233
7. Pastores S.M., Katz D.P., and Kvetan V. Splanchnic ischemia and gut mucosal injury in sepsis and the multiple organ dysfunction syndrome. Am J Gastroenterol 91 (1996) 1697
8. Holland J., Carey M., Hughes N., et al. Intraoperative splanchnic hypoperfusion, increased intestinal permeability, down-regulation of monocyte class II major histocompatibility complex expression, exaggerated acute phase response, and sepsis. Am J Surg 190 (2005) 393
9. Fukuroda T., Fujikawa T., Ozaki S., et al. Clearance of circulating endothelin-1 by ETB receptors in rats. Biochem Biophys Res Commun 199 (1994) 1461
10. Weitzberg E., Lundberg J.M., and Rudehill A. Elevated plasma levels of endothelin in patients with sepsis syndrome. Circ Shock 33 (1991) 222
11. Miura S., Fukumura D., Kurose I., et al. Roles of ET-1 in endotoxin-induced microcirculatory disturbance in rat small intestine. Am J Physiol 271 (1996) G461
12. Oldner A., Wanecek M., Goiny M., et al. The endothelin receptor antagonist bosentan restores gut oxygen delivery and reverses intestinal mucosal acidosis in porcine endotoxin shock. Gut 42 (1998) 696
13. Wilson M.A., Steeb G.D., and Garrison R.N. Endothelins mediate intestinal hypoperfusion during bacteremia. J Surg Res 55 (1993) 168
14. Clozel M., Ramuz H., Clozel J.P., et al. Pharmacology of tezosentan, new endothelin receptor antagonist designed for parenteral use. J Pharmacol Exp Ther 290 (1999) 840
15. Konrad D., Oldner A., Rossi P., et al. Differentiated and dose-related cardiovascular effects of a dual endothelin receptor antagonist in endotoxin shock. Crit Care Med 32 (2004) 1192
16. Somell A., Weitzberg E., Suneson A., et al. Effects of the dual endothelin receptor antagonist tezosentan and hypertonic saline/dextran on porcine endotoxin shock. Acta Physiol (Oxf) 190 (2007) 291
17. Rossi P., Wanecek M., Konrad D., et al. Tezosentan counteracts endotoxin-induced pulmonary edema and improves gas exchange. Shock 21 (2004) 543
18. Kuklin V., Kirov M., Sovershaev M., et al. Tezosentan-induced attenuation of lung injury in endotoxemic sheep is associated with reduced activation of protein kinase C. Crit Care 9 (2005) R211
19. Chin A., Radhakrishnan J., Fornell L., et al. Effects of tezosentan, a dual endothelin receptor antagonist, on the cardiovascular and renal systems of neonatal piglets during endotoxic shock. J Pediatr Surg 37 (2002) 482
20. Krejci V., Hiltebrand L.B., Erni D., et al. Endothelin receptor antagonist bosentan improves microcirculatory blood flow in splanchnic organs in septic shock. Crit Care Med 31 (2003) 203
21. Urbanowicz W., Sogni P., Moreau R., et al. Tezosentan, an endothelin receptor antagonist, limits liver injury in endotoxin challenged cirrhotic rats. Gut 53 (2004) 1844
22. Smits G.J., Roman R.J., and Lombard J.H. Evaluation of laser-Doppler flowmetry as a measure of tissue blood flow. J Appl Physiol 61 (1986) 666
23. Leahy M.J., de Mul F.F., Nilsson G.E., et al. Principles and practice of the laser-Doppler perfusion technique. Technol Health Care 7 (1999) 143
24. Hemsen A. Biochemical and functional characterization of endothelin peptides with special reference to vascular effects. Acta Physiol Scand 602 Suppl (1991) 1
25. De Backer D., Creteur J., Dubois M.J., et al. The effects of dobutamine on microcirculatory alterations in patients with septic shock are independent of its systemic effects. Crit Care Med 34 (2006) 403
26. Boerma E.C., van der Voort P.H., Spronk P.E., et al. Relationship between sublingual and intestinal microcirculatory perfusion in patients with abdominal sepsis. Crit Care Med 35 (2007) 1055
27. Oldner A. Splanchnic organ homeostasis in experimental endotoxin shock: With special reference to the endothelian and renin-angiotensin systems (1999), Department of Surgical Sciences, Karolinska Institutet, Stockholm
28. Oldner A., Wanecek M., Weitzberg E., et al. Differentiated effects on splanchnic homeostasis by selective and non-selective endothelin receptor antagonism in porcine endotoxaemia. Br J Pharmacol 127 (1999) 1793
29. Massberg S., Boros M., Leiderer R., et al. Endothelin (ET)-1 induced mucosal damage in the rat small intestine: Role of ET(A) receptors. Shock 9 (1998) 177
30. Boros M., Massberg S., Baranyi L., et al. Endothelin 1 induces leukocyte adhesion in submucosal venules of the rat small intestine. Gastroenterology 114 (1998) 103
31. Kuklin V., Sovershaev M., Andreasen T., et al. Tezosentan reduces the microvascular filtration coefficient in isolated lungs from rats subjected to cecum ligation and puncture. Crit Care 9 (2005) R677
32. Helset E., Kjaeve J., and Hauge A. Endothelin-1-induced increases in microvascular permeability in isolated, perfused rat lungs requires leukocytes and plasma. Circ Shock 39 (1993) 15
33. Reeder L.B., and Ferguson M.K. Endothelin-1 synthesis and receptor-mediated activity in porcine lymph vessels. J Surg Res 63 (1996) 215
34. Morin M.J., Unno N., Hodin R.A., et al. Differential expression of inducible nitric oxide synthase messenger RNA along the longitudinal and crypt-villus axes of the intestine in endotoxemic rats. Crit Care Med 26 (1998) 1258
35. Revelly J.P., Ayuse T., Brienza N., et al. Endotoxic shock alters distribution of blood flow within the intestinal wall. Crit Care Med 24 (1996) 1345
36. Scommotau S., Uhlmann D., Loffler B.M., et al. Involvement of endothelin/nitric oxide balance in hepatic ischemia/reperfusion injury. Langenbecks Arch Surg 384 (1999) 65
37. Hiltebrand L.B., Krejci V., and Sigurdsson G.H. Effects of dopamine, dobutamine, and dopexamine on microcirculatory blood flow in the gastrointestinal tract during sepsis and anesthesia. Anesthesiology 100 (2004) 1188
38. Pannen B.H., Bauer M., Zhang J.X., et al. A time-dependent balance between endothelins and nitric oxide regulating portal resistance after endotoxin. Am J Physiol 271 (1996) H1953
39. Baveja R., Kresge N., Ashburn J.H., et al. Potentiated hepatic microcirculatory response to endothelin-1 during polymicrobial sepsis. Shock 18 (2002) 415
40. Ayuse T., Brienza N., Revelly J.P., et al. Alternations in liver hemodynamics in an intact porcine model of endotoxin shock. Am J Physiol 268 (1995) H1106
41. Erdem A., Meltem Sevgili A., et al. Tezosentan attenuates organ injury and mesenteric blood flow decrease in endotoxemia and cecal ligation and puncture. J Surg Res 141 (2007) 211
42. Paxian M., Keller S.A., Baveja R., et al. Functional link between ETB receptors and eNOS maintain tissue oxygenation in the normal liver. Microcirculation 11 (2004) 435
43. Kamoun W.S., Karaa A., Kresge N., et al. LPS inhibits endothelin-1-induced endothelial NOS activation in hepatic sinusoidal cells through a negative feedback involving caveolin-1. Hepatology 43 (2006) 182
44. Konrad D., Haney M., Johansson G., et al. Cardiac effects of endothelin receptor antagonism in endotoxemic pigs. Am J Physiol Heart Circ Physiol 293 (2007) H988
45. 2 abnormalities in sepsis. Minerva Anesthesiol 72 (2006) 507
46. Creteur J., De Backer D., Sakr Y., et al. Sublingual capnometry tracks microcirculatory changes in septic patients. Intensive Care Med 32 (2006) 516
47. Lang C.H., Obih J.C., Bagby G.J., et al. Increased glucose uptake by intestinal mucosa and muscularis in hypermetabolic sepsis. Am J Physiol 261 (1991) G287
48. Crouser E.D., Julian M.W., Blaho D.V., et al. Endotoxin-induced mitochondrial damage correlates with impaired respiratory activity. Crit Care Med 30 (2002) 276